Literature DB >> 33317862

Inherited thrombocytopenias: an updated guide for clinicians.

Alessandro Pecci1, Carlo L Balduini2.   

Abstract

The great advances in the knowledge of inherited thrombocytopenias (ITs) made since the turn of the century have significantly changed our view of these conditions. To date, ITs encompass 45 disorders with different degrees of complexity of the clinical picture and very wide variability in the prognosis. They include forms characterized by thrombocytopenia alone, forms that present with other congenital defects, and conditions that predispose to acquire additional diseases over the course of life. In this review, we recapitulate the clinical features of ITs with emphasis on the forms predisposing to additional diseases. We then discuss the key issues for a rational approach to the diagnosis of ITs in clinical practice. Finally, we aim to provide an updated and comprehensive guide to the treatment of ITs, including the management of hemostatic challenges, the treatment of severe forms, and the approach to the manifestations that add to thrombocytopenia.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inherited thrombocytopenia; bleeding disorders; germline predisposition; platelet disorders; platelet dysfunction; thrombopoietin-receptor agonists

Year:  2020        PMID: 33317862     DOI: 10.1016/j.blre.2020.100784

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  8 in total

Review 1.  Genetics of inherited thrombocytopenias.

Authors:  Julia T Warren; Jorge Di Paola
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

2.  Reduced platelet forces underlie impaired hemostasis in mouse models of MYH9-related disease.

Authors:  Juliane Baumann; Laura Sachs; Oliver Otto; Ingmar Schoen; Peter Nestler; Carlo Zaninetti; Martin Kenny; Ruth Kranz; Hendrik von Eysmondt; Johanna Rodriguez; Tilman E Schäffer; Zoltan Nagy; Andreas Greinacher; Raghavendra Palankar; Markus Bender
Journal:  Sci Adv       Date:  2022-05-18       Impact factor: 14.957

Review 3.  Treatment of inherited thrombocytopenias.

Authors:  Carlo L Balduini
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

Review 4.  Inherited Platelet Disorders: An Updated Overview.

Authors:  Verónica Palma-Barqueros; Nuria Revilla; Ana Sánchez; Ana Zamora Cánovas; Agustín Rodriguez-Alén; Ana Marín-Quílez; José Ramón González-Porras; Vicente Vicente; María Luisa Lozano; José María Bastida; José Rivera
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

5.  Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.

Authors:  James B Bussel; Christine A Garcia
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

6.  Platelet function testing: Current practice among clinical centres in Northern Europe.

Authors:  Timea Szanto; Eva Zetterberg; Sofia Ramström; Eva B Leinøe; Pål A Holme; Jovan P Antovic; Margareta Holmström; Pall T Onundarson; Marika Pikta; Ines Vaide; Anna Olsson; Maria Magnusson; Satu Kärkkäinen; Manar Bitar; Lone Hvitfeldt Poulsen; Riitta Lassila
Journal:  Haemophilia       Date:  2022-05-05       Impact factor: 4.263

Review 7.  Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases.

Authors:  Hrushikesh Vyas; Ahmad Alcheikh; Gillian Lowe; William S Stevenson; Neil V Morgan; David J Rabbolini
Journal:  Platelets       Date:  2022-05-19       Impact factor: 4.236

8.  The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.

Authors:  Eva Leinøe; Nanna Brøns; Andreas Ørslev Rasmussen; Migle Gabrielaite; Carlo Zaninetti; Raghavendra Palankar; Eva Zetterberg; Steen Rosthøj; Sisse Rye Ostrowski; Maria Rossing
Journal:  J Thromb Haemost       Date:  2021-08-11       Impact factor: 16.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.